JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB286958

AZD-3965

AZD-3965

Be the first to review this product! Submit a review

|

(1 Publication)

MW 515.5 Da, Purity >98%. A potent and selective monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM; it is 6-fold selective over MCT2 and does not inhibit MCT4 even at 10 μM. AZD 3965 increases intratumor lactate levels and decreases tumor growth in mice bearing COR-L103 small cell lung cancer (SCLC) xenografts.

查看别名

FLJ36745, HHF7, MCT, MCT 1, MGC44475, MOT1_HUMAN, Monocarboxylate transporter, Monocarboxylate transporter 1, Monocarboxylate transporter isoform 1, Monocarboxylic acid transporter 1, SLC16A1 protein, Slc16a1, Solute carrier family 16 (monocarboxylic acid transporters) member 1, Solute carrier family 16 member 1, Solute carrier family 16 member 1 (monocarboxylic acid transporter 1)

关键信息

CAS 号

1448671-31-5

纯度

>98%

形式

Solid

form

分子量

515.5 Da

分子式

C<sub>2</sub><sub>1</sub>H<sub>2</sub><sub>4</sub>F<sub>3</sub>N<sub>5</sub>O<sub>5</sub>S

PubChem

10369242

属性

Synthetic

溶解度

Soluble in DMSO to 100 mM

Soluble in ethanol to 100 mM

生化试剂名称

(S)-5-(4-Hydroxy-4-methylisoxazolidine-2-carbonyl)-1-isopropyl-3-methyl-6-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione

生物学描述

A potent and selective monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM; it is 6-fold selective over MCT2 and does not inhibit MCT4 even at 10 μM. AZD 3965 increases intratumor lactate levels and decreases tumor growth in mice bearing COR-L103 small cell lung cancer (SCLC) xenografts.

经典 SMILES

CC1=C(C(=NN1)C(F)(F)F)CC2=C(C3=C(S2)N(C(=O)N(C3=O)C)C(C)C)C(=O)N4CC(CO4)(C)O

同分异构的 SMILES

CC1=C(C(=NN1)C(F)(F)F)CC2=C(C3=C(S2)N(C(=O)N(C3=O)C)C(C)C)C(=O)N4C[C@](CO4)(C)O

InChi

InChI=1S/C21H24F3N5O5S/c1-9(2)29-18-14(16(30)27(5)19(29)32)13(17(31)28-7-20(4,33)8-34-28)12(35-18)6-11-10(3)25-26-15(11)21(22,23)24/h9,33H,6-8H2,1-5H3,(H,25,26)/t20-/m0/s1

InChiKey

PRNXOFBDXNTIFG-FQEVSTJZSA-N

IUPAC 名

5-[(4S)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione

产品详情

This product is manufactured by BioVision, an Abcam company and was previously called B2227 AZD-3965. B2227-1 is the same size as the 1 mg size of ab286958.

性能和储存信息

运输条件
Blue Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
Store in the dark|Store under desiccating conditions|This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

MCT1 also known as Monocarboxylate Transporter 1 or SLC16A1 is a protein that facilitates the transport of monocarboxylates such as lactate and pyruvate across cell membranes. The approximate molecular weight of MCT1 is 51 kDa. This transporter expresses in many tissues including muscle brain liver and kidney. Its widespread presence indicates a significant role in cellular metabolism and energy balance across different biological systems.
Biological function summary

MCT1 acts as an important transport mechanism for lactate and pyruvate driving the cellular uptake and release processes of these molecules. It partners with CD147 also known as Basigin to form a functional heteromeric complex. This binding allows the correct localization and stabilization of MCT1 in the plasma membrane ensuring effective transport activity. The presence of MCT1 in metabolically active tissues highlights its role in maintaining homeostasis in energy-rich environments.

Pathways

MCT1 plays a significant role in the glycolysis and gluconeogenesis pathways by mediating lactate transport which connects anaerobic and aerobic metabolic processes. Through these pathways MCT1 associates with key metabolic enzymes like lactate dehydrogenase (LDH) that regulate the conversion between lactate and pyruvate. This association provides a link between lactate production and consumption thereby controlling pH levels and preventing the buildup of metabolic intermediates that can disrupt cellular functions.

MCT1 is implicated in cancer and metabolic acidosis. In cancer elevated expression of MCT1 supports the Warburg effect a phenomenon where cancer cells rely on aerobic glycolysis leading to increased lactate production. MCT1 works alongside proteins such as CD147 influencing tumor growth and metastasis by promoting lactate export. In metabolic acidosis impaired MCT1 function can disrupt lactate clearance affecting tissue pH balance and contributes to conditions like lactic acidosis. Understanding MCT1's role in these diseases highlights the importance of targeting its function for therapeutic purposes.

产品实验方案

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Molecular cancer therapeutics 13:2805-16 PubMed25281618

2014

Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport.

Applications

Unspecified application

Species

Unspecified reactive species

Becky M Bola,Amy L Chadwick,Filippos Michopoulos,Kathryn G Blount,Brian A Telfer,Kaye J Williams,Paul D Smith,Susan E Critchlow,Ian J Stratford
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com